Literature DB >> 29862656

Comparative assessment of intraocular inflammation following standard or heavy silicone oil tamponade: a prospective study.

Francesco Semeraro1, Andrea Russo1, Francesco Morescalchi1, Elena Gambicorti1, Sara Vezzoli2, Francesco Parmeggiani3, Mario R Romano4, Ciro Costagliola5.   

Abstract

PURPOSE: To evaluate the inflammation associated with the use of standard silicone oil (polydimethylsiloxane; PDMS) and heavy silicone oil (HSO) Densiron-68™ in patients undergoing vitrectomy for retinal detachment.
MATERIALS AND METHODS: A prospective study was performed involving 35 patients scheduled to undergo vitrectomy for retinal detachment. Patients received PDMS or Densiron-68™ HSO according to superior or inferior retinal localization of the tears, respectively. For assessing the inflammation, prostaglandin E2 (PGE2 ) and interleukin-1α (IL-1α) levels were evaluated in the aqueous.
RESULTS: Thirty-five eyes of 35 patients completed the study: 20 eyes received HSO, and 15 eyes received PDMS. The mean aqueous PGE2 level was significantly higher in HSO patients than in PDMS patients (869.16 ± 242.83 pg/ml versus 369.38 ± 209.7 pg/ml, respectively; p < 0.0001). The mean aqueous IL-1α level was also significantly higher in HSO patients than in PDMS patients (81.40 ± 36.9 pg/ml versus 40.8 ± 32.5 pg/ml, respectively; p = 0.002). In HSO, a moderate positive correlation between the endotamponade duration and both PGE2 (r = 0.44; p = 0.05) and IL-1α (r = 0.48; p = 0.033) levels was observed. In PDMS, a strong positive correlation between the endotamponade duration and both PGE2 (r = 0.89; p < 0.0001) and IL-1α (r = 0.68; p = 0.006) levels was observed.
CONCLUSION: Although both HSO and PDMS yielded favourable success rates in the surgical treatment of complicated retinal detachments, HSO triggered a more severe inflammatory reaction, in a time-dependent manner.
© 2018 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  heavy silicone oil; inflammation; retinal detachment; standard silicone oil; vitrectomy

Mesh:

Substances:

Year:  2018        PMID: 29862656     DOI: 10.1111/aos.13830

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  6 in total

Review 1.  Biocompatibility of intraocular liquid tamponade agents: an update.

Authors:  Mario R Romano; Mariantonia Ferrara; Irene Nepita; Jana D'Amato Tothova; Alberto Giacometti Schieroni; Daniela Reami; Raniero Mendichi; Libero Liggieri; Rodolfo Repetto
Journal:  Eye (Lond)       Date:  2021-05-25       Impact factor: 4.456

2.  Heavy Silicone Oil as an Endotamponade in Recurrent or Complicated Retinal Detachment and Macular Hole

Authors:  Rengin Aslıhan Kurt; Ziya Kapran
Journal:  Turk J Ophthalmol       Date:  2022-04-28

3.  Outcomes of Heavy Silicone Oil (Densiron) compared to Silicone Oil in primary rhegmatogenous retinal detachment: a multivariable regression model.

Authors:  George Moussa; Maria Tadros; Soon Wai Ch'ng; Ash Sharma; Kim Son Lett; Arijit Mitra; Ajai K Tyagi; Walter Andreatta
Journal:  Int J Retina Vitreous       Date:  2022-09-03

Review 4.  Retinal and Corneal Changes Associated with Intraocular Silicone Oil Tamponade.

Authors:  Mariantonia Ferrara; Giulia Coco; Tania Sorrentino; Kirti M Jasani; George Moussa; Francesco Morescalchi; Felipe Dhawahir-Scala; Francesco Semeraro; David H W Steel; Vito Romano; Mario R Romano
Journal:  J Clin Med       Date:  2022-09-05       Impact factor: 4.964

5.  Comparative Study of Chemical Composition, Molecular and Rheological Properties of Silicone Oil Medical Devices.

Authors:  Raniero Mendichi; Alberto Giacometti Schieroni; Daniele Piovani; Davide Allegrini; Mariantonia Ferrara; Mario R Romano
Journal:  Transl Vis Sci Technol       Date:  2019-09-11       Impact factor: 3.283

6.  Comparative Biochemical Outcomes, Effectiveness and Tolerance of Densiron 68 and Oxane HD for the Management of Complicated Retinal Detachment

Authors:  Chafik Keilani; Edouard Augstburger; Mathieu Robin; Amélie Beaugrand; Raphaëlle Ores; José-Alain Sahel; Sarah Ayello-Scheer
Journal:  Turk J Ophthalmol       Date:  2019-12-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.